LSE creators

Number of items: 14.
2024
  • Hill, Andrew, Tovar sanchez, Tamara, Delaporte, Eric, Sokhela, Simiso, Simmons, Bryony, Kouanfack, Charles, Mccann, Kaitlyn, Levi, Jacob, Fairhead, Cassandra, Venter, Francois (2024). Low CD4 counts predict excessive weight gains during first-line treatment for HIV. Journal of Antimicrobial Chemotherapy, 79(9), 2369 - 2378. https://doi.org/10.1093/jac/dkae238 picture_as_pdf
  • Simmons, Bryony, Sicuri, Elisa, Carter, Jane, Hailu, Asrat, Kiemde, Francois, Mens, Petra, Mumbengegwi, Davis, Nour, Bakri, Paulussen, RenĂ© & Schallig, Henk et al (2024). Defining a malaria diagnostic pathway from innovation to adoption: stakeholder perspectives on data and evidence gaps. PLOS Global Public Health, 4(5). https://doi.org/10.1371/journal.pgph.0002957 picture_as_pdf
  • Simmons, Bryony, Namale, Phiona E., Boloko, Linda, Vermeulen, Marcia, Haigh, Kate A., Bagula, Fortuna, Maseko, Alexis, Sossen, Bianca, Lee-Jones, Scott & Msomi, Yoliswa et al (2024). Additional file 1 of Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial. [Dataset]. figshare. https://doi.org/10.6084/m9.figshare.25779268
  • Namale, Phiona E., Boloko, Linda, Vermeulen, Marcia, Haigh, Kate A., Bagula, Fortuna, Maseko, Alexis, Sossen, Bianca, Lee-Jones, Scott, Msomi, Yoliswa & McIlleron, Helen et al (2024). Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trial. Trials, 25(1). https://doi.org/10.1186/s13063-024-08119-4 picture_as_pdf
  • Sokhela, Simiso, Venter, Willem D.F., Bosch, Bronwyn, Woods, Joana, McCann, Kaitlyn, Akpomiemie, Godspower, Chandiwana, Nomathemba, Mashabane, Nkuli, Tembo, Angela & Simmons, Bryony et al (2024). Final 192-week efficacy and safety results of the ADVANCE trial, comparing 3 first-line antiretroviral regimens. Open Forum Infectious Diseases, 11(3). https://doi.org/10.1093/ofid/ofae007 picture_as_pdf
    • 2023
  • Tovar Sanchez, Tamara, Mpoudi-Etame, Mireille, Kouanfack, Charles, Delaporte, Eric, Calmy, Alexandra, Venter, Francois, Sokhela, Simiso, Bosch, Bronwyn, Akpomiemie, Godspower & Tembo, Angela et al (2023). Risks of metabolic syndrome in the ADVANCE and NAMSAL trials. Frontiers in Reproductive Health, 5, https://doi.org/10.3389/frph.2023.1133556 picture_as_pdf
  • Bosch, B., Sokhela, S., Akpomiemie, G., Chandiwana, N., Venter, W.D.F., Simmons, Bryony, McCann, K., Mirchandani, M., Hill, A. (2023). High rates of long-term HIV RNA re-suppression after virological failure on dolutegravir in the ADVANCE trial. Journal of the International AIDS Society, 26(S3), 11 - 11. https://doi.org/10.1002/jia2.26134
  • Griesel, Rulan, Zhao, Ying, Simmons, Bryony, Omar, Zaayid, Wiesner, Lubbe, Keene, Claire M., Hill, Andrew M., Meintjes, Graeme, Maartens, Gary (2023). Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial. The Lancet HIV, 10(7), e433 - e441. https://doi.org/10.1016/S2352-3018(23)00081-4 picture_as_pdf
  • Haile Mariam, Damon, Estifanos, Abiy, Wondimagegn, Dawit, Simmons, Bryony, Conteh, Lesong (2023). Optimizing the Ethiopian health extension programme: strategies to address workforce challenges. (AHOP Policy Briefs). World Health Organization Regional Office for Africa. picture_as_pdf
  • Zhao, Ying, Griesel, Rulan, Omar, Zaayid, Simmons, Bryony, Hill, Andrew, van Zyl, Gert, Keene, Claire, Maartens, Gary, Meintjes, Graeme (2023). Initial supplementary dose of Dolutegravir in second-line antiretroviral therapy: a noncomparative, double-blind, randomized placebo-controlled trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 76(10), 1832-1840. https://doi.org/10.1093/cid/ciad023 picture_as_pdf
    • 2022
  • Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony, Woods, Joana, Johnstone, Hilary, Madhi, Shabir, Qavi, Ambar, Ellis, Leah & Akpomiemie, Godspower et al (2022). Comparing prospective incident severe acute respiratory syndrome Coronavirus 2 infection rates during successive waves of Delta and Omicron in Johannesburg, South Africa. Open Forum Infectious Diseases, 9(12). https://doi.org/10.1093/ofid/ofac587 picture_as_pdf
  • Sokhela, Simiso, Bosch, Bronwyn, Hill, Andrew, Simmons, Bryony, Woods, Joana, Johnstone, Hilary, Akpomiemie, Godspower, Ellis, Leah, Owen, Andrew & Casas, Carmen Perez et al (2022). Randomized clinical trial of nitazoxanide or sofosbuvir/daclatasvir for the prevention of SARS-CoV-2 infection. The Journal of Antimicrobial Chemotherapy, 77(10), 2706 - 2712. https://doi.org/10.1093/jac/dkac266 picture_as_pdf
  • Kiemde, Francois, Tinto, Halidou, Carter, Jane, Rouamba, Toussaint, Valia, Daniel, Conteh, Lesong, Sicuri, Elisa, Simmons, Bryony, Nour, Bakri & Mumbengegwi, Davis et al (2022). Phase 3 evaluation of an innovative simple molecular test for the diagnosis of malaria in different endemic and health settings in sub-Saharan Africa (DIAGMAL). PLOS ONE, 17(9), e0272847. https://doi.org/10.1371/journal.pone.0272847 picture_as_pdf
  • Cann, Alexandra, Cooke, Graham S., Clarke, Candice, Brown, Jonathan, Thomson, Tina, Prendecki, Maria, Moshe, Maya, Badhan, Anjna, Simmons, Bryony & Klaber, Bob et al (2022). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study. Wellcome Open Research, 6, https://doi.org/10.12688/wellcomeopenres.17231.2 picture_as_pdf